Optimizing the R&D process using spin-outs: case studies from the pharmaceutical industry: R&D spin-outs can offer an attractive mechanism for increasing the effectiveness and reach of R&D activities while maintaining the focus of the core business. A study of 42 spin-outs in the European pharmaceutical industry reveals the attributes that lead to successful spin-outs and illustrate the possible advantages of spin-outs

MLA

Festel, Gunter, et al. “Optimizing the R&D Process Using Spin-Outs: Case Studies from the Pharmaceutical Industry: R&D Spin-Outs Can Offer an Attractive Mechanism for Increasing the Effectiveness and Reach of R&D Activities While Maintaining the Focus of the Core Business. A Study of 42 Spin-Outs in the European Pharmaceutical Industry Reveals the Attributes That Lead to Successful Spin-Outs and Illustrate the Possible Advantages of Spin-Outs.” Research-Technology Management, vol. 54, no. 1, Jan. 2011, p. 32. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.246178190&authtype=sso&custid=ns315887.

APA

Festel, G., De Cleyn, S. H., Boutellier, R., & Braet, J. (2011, January 1). Optimizing the R&D process using spin-outs: case studies from the pharmaceutical industry: R&D spin-outs can offer an attractive mechanism for increasing the effectiveness and reach of R&D activities while maintaining the focus of the core business. A study of 42 spin-outs in the European pharmaceutical industry reveals the attributes that lead to successful spin-outs and illustrate the possible advantages of spin-outs. Research-Technology Management, 54(1), 32.

Chicago

Festel, Gunter, Sven H. De Cleyn, Roman Boutellier, and Johan Braet. 2011. “Optimizing the R&D Process Using Spin-Outs: Case Studies from the Pharmaceutical Industry: R&D Spin-Outs Can Offer an Attractive Mechanism for Increasing the Effectiveness and Reach of R&D Activities While Maintaining the Focus of the Core Business. A Study of 42 Spin-Outs in the European Pharmaceutical Industry Reveals the Attributes That Lead to Successful Spin-Outs and Illustrate the Possible Advantages of Spin-Outs.” Research-Technology Management, January 1. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.246178190&authtype=sso&custid=ns315887.